Health Condition 1: M797- Fibromyalgia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age group 18 to 59 years irrespective of their sex socioeconomic status and occupation Participants diagnosed with fibromyalgia according to the american college of rheumatology 2016 criteria Participants who have willingly joined the study and signed the written informed consent form Participants currently taking medications from other systems of medicine will be enrolled only after completing a two-week washout period provided they are willing to discontinue such medicines The occasional use of mild painkillers example paracetamol will be permitted The number and frequency of painkiller doses will be carefully documented at baseline and monitored throughout the study for comparison before and after treatment
Exclusion criteria
Exclusion criteria: Participants diagnosed with other chronic pain syndromes Participants diagnosed with hypothyroidism Participants with severe alcohol dependence Presence of severe psychiatric illness Pregnant or lactating women Participants diagnosed with other immunocompromised conditions and autoimmune diseases Participant on medications that cannot be safely stopped or tapered without the authorized physician supervision or where such supervision is unavailable.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the changes in pain fatigue levels and sleep quality using Revised Fibromyalgia Impact Questionnaire before and after giving individualized Homoeopathic medicinesTimepoint: 16 months study 6 months enrolment 6 months follow up 2 months data analysis 2 months report writing Revised fibromyalgia impact questionnaire is used statistical data analysis done at baseline 3rd month and 6th month | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the change in stress levels among participants receiving individualized Homoeopathic treatment using the Perceived Stress ScaleTimepoint: 16 months study 6 months enrolment 6 months follow up 2 months data analysis 2 months report writing Revised fibromyalgia impact questionnaire is used statistical data analysis done at baseline 3rd month and 6th month;To evaluate the changes in quality of life in fibromyalgia participants following individualized homoeopathic management, measured by the EQ 5D 5L EuroQol 5 Dimension 5 Level questionnaire.Timepoint: 16 months study 6 months enrolment 6 months follow up 2 months data analysis 2 months report writing Revised fibromyalgia impact questionnaire is used statistical data analysis done at baseline 3rd month and 6th month | — |
Countries
India
Contacts
Bakson homoeopathic medical college and hospital